China Regulatory Environment Reforms-the Next Five to Ten Years

China has experienced a fast-growing economy for more than 30 years and has now become the second largest pharmaceutical market in the world. However, the drug regulatory environment in China still poses many challenges and most stakeholders consider it to be one of the most difficult regulatory environments to understand and navigate. Learn more about the current regulatory environment and latest reforms in China in this new white paper.

To download the white paper, please complete the form below. Fields marked with * are required. Pharmaceutical Product Development, LLC and its affiliates (together “PPD”) will use the information you provide on this page for the purposes of sending you the requested white paper and possibly following up with you. Important information on how PPD handles personal data and what rights you may have under data privacy laws are included within PPD’s Global Privacy Policy.

Download Registration Form